Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-30T20:09:04.789Z Has data issue: false hasContentIssue false
  • English
  • Français

Zero Tolerance for Catheter-Related Bloodstream Infections: The Unnegotiable Objective

Published online by Cambridge University Press:  02 January 2015

Issam I. Raad
Issam I. Raad*
Affiliation:
University of Texas M. D. Anderson Cancer Center, Houston, Texas
*
University of Texas, M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1460, Houston, TX 77030 ([email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Commentary
Information
Infection Control & Hospital Epidemiology , Volume 29 , Issue 10 , October 2008 , pp. 951 - 953
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Raad, I, Hanna, H, Maki, D. Intravascular catheter-related infections: advances in diagnosis, prevention, and management. Lancet Infect Dis 2007;7:645–657.CrossRefGoogle ScholarPubMed
2.Lee, D, Jung, K, Choi, Y. The use of maximal sterile barrier precautions and/or antimicrobial-coated catheters to reduce the risk of central venous catheter-related bloodstream infection. Infect Control Hosp Epidemiol 2008;29:947–950 (in this issue).CrossRefGoogle ScholarPubMed
3.Raad, II, Hohn, DC, Gilbreath, BJ, et al.Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertions. Infect Control Hosp Epidemiol 1994; 15(4 Pt 1):231–238.Google Scholar
4.Pronovost, P, Needham, D, Berenholtz, S, et al.An intervention to decrease catheter-related bloodstream infections in the ICU (published correction appears in N Engl J Med 2007;356:2660). N Engl J Med 2006;355:2725–2732.Google Scholar
5.Ramritu, P, Hal ton, K, Collignon, P, et al.A systemic review comparing the relative effectiveness of antimicrobial-coated catheters in intensive care units. Am J Infect Control 2008;36:104–117.Google Scholar
6.Falagas, ME, Fragoulis, K, Bliziotis, IA, Chatzinikolaou, I. Rifampicin-impregnated central venous catheters: a meta-analysis of randomized controlled trials. J Antimicrob Chemother 2007;59:359–369.Google Scholar
7.Crnich, CJ, Maki, DG. Are antimicrobial-impregnated catheters effective? Don't throw out the baby with the bathwater. Clin Infect Dis 2004;38:1287–1292.Google Scholar
8.Shorr, AF, Humphreys, CW, Helman, DL. New choices for central venous catheters. Potential financial implications. Chest 2003;124:275–284.Google Scholar
9.Chatzinikolaou, I, Hanna, H, Graviss, L, et al.Clinical experience with minocycline and rifampin-impregnated central venous cathetersin bone marrow transplantation recipients: efficacy and low risk of developing staphylococcal resistance. Infect Control Hosp Epidemiol 2003;24:961–963.Google Scholar
10.Hanna, H, Benjamin, R, Chatzinikolaou, I, et al.Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial (published correction appears in J Clin Oncol 2005;23:3652). J Clin Oncol 2004;22:3163–3171.Google Scholar
11.Rupp, ME, Lisco, SJ, Lipsett, PA, et al.Effect of second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial. Ann Intern Med 2005;143:570–580.Google Scholar
12.Raad, I, Darouiche, R, Hachem, R, Mansouri, M, Bodey, GP. The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin. J Infect Dis 1996;173:418–424.Google Scholar
13.Marik, PE, Abraham, G, Careau, P, Varon, J, Fromm, RE Jr. The ex vivo antimicrobial activity and colonization rate of two antimicrobial-bonded central venous catheters. Crit Care Med 1999;27:1128–1131.Google Scholar
14.Raad, II, Darouiche, RO, Hachem, R, et al.Antimicrobial durability and rare ultrastructural colonization of indwelling central catheters coated with minocycline and rifampin. Crit Care Med 1998;26:219–224.CrossRefGoogle ScholarPubMed
15.Centers for Disease Control and Prevention (CDC). Progress toward interruption of wild poliovirus transmission—worldwide, January 2007-April 2008. MMWR Morb Mortal Wkly Rep 2008;57:489–494.Google Scholar